Septo Optic Dysplasia Improvements with Stem Cell Treatment

Written By: Nishat Arfin | Reviewed By: Viezec Medical Team | Published: October 18, 2023 | Updated: October 12, 2026

Septo-optic dysplasia (SOD), also called de Morsier syndrome, is a rare condition present from birth. It involves an underdeveloped optic nerve, pituitary hormone problems and differences in the midline structures of the brain. Doctors diagnose it when at least two of these three features are present.

There is no cure. Care centres on hormone replacement, vision support and developmental therapy. Stem cell therapy for SOD is investigational. Current evidence does not show that it restores vision, and it should never replace proven endocrine and developmental care.

What is septo-optic dysplasia?

SOD affects roughly 1 in 10,000 babies, boys and girls equally. No two children look exactly alike. Some have mild vision differences with one hormone gap. Others have significant vision loss, several hormone deficiencies and developmental needs.

The three defining features are:

Optic nerve hypoplasia (ONH). One or both optic nerves are smaller than usual, so less visual information reaches the brain. Vision can range from near-normal to severely reduced.
Hypothalamic-pituitary problems. The brain’s hormone control centre does not make enough of certain hormones. Growth hormone is most often affected, followed by cortisol (ACTH), thyroid hormone, sex hormones and antidiuretic hormone.
Midline brain differences. The most common is a missing or incomplete septum pellucidum. Sometimes the corpus callosum, the bridge between the two brain halves, is also thin or absent.

Some children also have seizures, cortical malformations or other features. This is sometimes called “SOD-plus”.

What causes it?

In most families the cause is not found. SOD usually occurs by chance and is rarely inherited. Changes in genes involved in early brain development, including HESX1, SOX2, SOX3 and OTX2, have been found in a minority of children. Researchers have also studied links to very young maternal age and certain pregnancy exposures, but no single cause has been proven. Parents should know that nothing they did caused SOD.

Signs parents may notice

Signs vary with age:

Newborns. Low blood sugar, prolonged jaundice, or very small genitalia in boys. These can point to pituitary deficiency.
Infants. Wandering or shaky eye movements (nystagmus), poor eye contact, or not following faces and lights.
Toddlers and children. Slow growth, delayed milestones, feeding or sleep difficulties, or excessive thirst and urination.
Older children and teens. Delayed or absent puberty, fatigue, or weight gain.

Any of these deserves a prompt visit to a paediatrician, ophthalmologist or paediatric endocrinologist.

How SOD is diagnosed

No single test confirms SOD. Specialists put together several findings:

Eye examination. An ophthalmologist checks the optic nerves, eye movements and how well the child sees.
MRI of the brain. This shows the optic nerves, pituitary gland, septum pellucidum and corpus callosum.
Hormone testing. Blood tests and sometimes stimulation tests find pituitary deficiencies.
Genetic testing, in selected cases.

Hormone problems can appear years after birth, so endocrine checks continue throughout childhood, even if early results are normal.

Standard treatment and care

Good SOD care is coordinated by several specialists working together.

Hormone replacement. Growth hormone, thyroid hormone, cortisol and desmopressin are given as needed. Cortisol replacement is especially important. During fever, vomiting or injury, a child with cortisol deficiency may need extra doses, and a missed dose can become an emergency.
Vision care. Glasses, treatment for amblyopia (“lazy eye”), low-vision aids and classroom support help a child use the vision they have. Visual function can sometimes improve somewhat through early childhood as the visual system matures.
Developmental therapy. Early-intervention programmes, physiotherapy, occupational therapy and speech therapy support motor, language and learning skills. See also our overview of rehabilitation therapy.
Sleep, behaviour and appetite support. Some children benefit from sleep guidance, and from careful monitoring if appetite regulation is affected.
Regular reviews with paediatric endocrinology, ophthalmology and neurology.

With good hormone management, most people with SOD have a normal life expectancy.

Stem cell therapy and SOD: what the research shows

Families searching for hope often find websites promising vision recovery. Here is the honest picture.

Vision and the optic nerve. In optic nerve hypoplasia the nerve did not fully form before birth. This differs from nerves damaged later in life, such as in optic nerve atrophy, where researchers study whether protective or regenerative effects are possible. A controlled study of stem cell therapy in children with ONH found no improvement in visual acuity or optic nerve structure compared with controls. That direct finding is the most important piece of evidence we have, and families should hear it clearly.

Wider developmental effects. Some small studies of stem cell treatments in related paediatric neurological conditions, mostly using cord blood or mesenchymal cells, have reported perceived benefits. These studies differ widely in design and size, many lack proper control groups, and they were not done in SOD specifically. They are a reason for more research, not proof of benefit.

Where that leaves families:

Stem cell therapy is not an approved treatment for SOD.
It does not replace hormone therapy, which can be life-saving.
Any investigational approach should be discussed with your child’s treating specialists first, and ideally sit inside a regulated clinical trial.
Be cautious of any provider that guarantees improved vision.

To understand the broader science and its limits, read about the limits of stem cell therapy and stem cell treatment safety. For related eye conditions, see our pages on optic nerve hypoplasia, optic neuropathy and optic nerve regeneration research.

Day-to-day tips for families

Keep a written hormone schedule and an emergency plan, including what to do during illness.
Carry a medical alert card or bracelet if your child has cortisol deficiency.
Ask for a school vision assessment and request large print, contrast and seating adjustments.
Start therapy early. Progress comes from consistency, not one intervention.
Book repeat endocrine reviews, since new deficiencies can emerge later.
Connect with other SOD families and support groups. Caregiver wellbeing matters too.

Frequently asked questions

Does stem cell therapy improve vision in septo-optic dysplasia?
Current controlled research has not shown improved visual acuity or optic nerve structure in children with optic nerve hypoplasia. Families should not expect vision restoration.

Is SOD genetic?
Most cases are sporadic. A minority are linked to gene changes such as HESX1, SOX2 or OTX2. Genetic counselling can help if you are concerned.

Can a child with SOD see?
Many do. Vision ranges from near-normal to severely reduced, and it often differs between the two eyes.

What is the life expectancy with SOD?
Most people with well-managed hormone replacement have a normal life expectancy. The main acute risk is untreated cortisol deficiency during illness.

Can SOD be found before birth?
Not reliably. It is usually recognised in infancy through eye movement changes, vision concerns or low blood sugar, then confirmed with MRI and hormone tests.

Will my child’s vision get worse over time?
Optic nerve hypoplasia itself does not progress, and some children improve a little as the visual system develops. Regular eye checks catch treatable problems such as refractive error or amblyopia.

Want your child’s reports reviewed? Book a free consultation. Our team will explain what current evidence does and does not support for your child’s case.

This article is for education only and is not medical advice. Consult your child’s endocrinologist and ophthalmologist before any treatment decision.